Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
PubMatic
PUBM
$804M
| $1.84M | ﹤0.01% |
112,574
-120,252
| -52% | -$1.74M |
|
4427
CALL
ScottsMiracle-Gro
SMG
$3.61B
| $1.84M | ﹤0.01% |
28,800
-29,800
| -51% | -$1.61M |
|
4428
Renasant Corp
RNST
$3.92B
| $1.83M | ﹤0.01% |
54,415
+27,643
| +103% | +$775K |
|
4429
CALL
Rithm Capital
RITM
$5.72B
| $1.83M | ﹤0.01% |
171,400
+20,400
| +14% | +$203K |
|
4430
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.07B
| $1.83M | ﹤0.01% |
31,721
-18,199
| -36% | -$956K |
|
|
SLNO
4431
DELISTED
Soleno Therapeutics
SLNO
| $1.83M | ﹤0.01% |
+45,456
| New | +$1.29M |
|
4432
CALL
Viking Therapeutics
VKTX
$3.94B
| $1.83M | ﹤0.01% |
98,300
-33,300
| -25% | -$436K |
|
4433
VanEck Africa Index ETF
AFK
$104M
| $1.83M | ﹤0.01% |
132,547
+1,513
| +1% | +$20.8K |
|
4434
Neurocrine Biosciences
NBIX
$16.5B
| $1.83M | ﹤0.01% |
13,880
-73,958
| -84% | -$8.51M |
|
4435
Denison Mines
DNN
$3B
| $1.83M | ﹤0.01% |
1,043,970
-27,816
| -3% | -$46.5K |
|
4436
Roundhill Generative AI & Technology ETF
CHAT
$1.85B
| $1.83M | ﹤0.01% |
59,159
-13,488
| -19% | -$385K |
|
4437
Invesco BulletShares 2029 High Yield Corporate Bond ETF
BSJT
$578M
| $1.83M | ﹤0.01% |
86,235
+42,032
| +95% | +$850K |
|
4438
Global X Blockchain ETF
BKCH
$200M
| $1.83M | ﹤0.01% |
39,476
+14,138
| +56% | +$431K |
|
|
MDRX
4439
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.82M | ﹤0.01% |
+173,800
| New | +$2.13M |
|
4440
CALL
Par Pacific Holdings
PARR
$3.78B
| $1.82M | ﹤0.01% |
50,100
-1,600
| -3% | -$53.9K |
|
4441
Ouster
OUST
$3.25B
| $1.82M | ﹤0.01% |
237,310
+193,101
| +437% | +$1.01M |
|
4442
Globe Life
GL
$14.1B
| $1.82M | ﹤0.01% |
14,953
-33,583
| -69% | -$3.95M |
|
4443
T. Rowe Price QM US Bond ETF
TAGG
$2.39B
| $1.82M | ﹤0.01% |
42,340
-32,170
| -43% | -$1.33M |
|
4444
OFG Bancorp
OFG
$2.22B
| $1.82M | ﹤0.01% |
48,542
+13,494
| +39% | +$444K |
|
4445
CALL
HDFC Bank
HDB
$120B
| $1.82M | ﹤0.01% |
54,200
-71,400
| -57% | -$2.15M |
|
4446
Chesapeake Utilities
CPK
$3.22B
| $1.82M | ﹤0.01% |
17,209
+11,709
| +213% | +$1.12M |
|
4447
Cytek Biosciences
CTKB
$616M
| $1.82M | ﹤0.01% |
199,248
+153,129
| +332% | +$964K |
|
4448
PUT
Sempra
SRE
$55.9B
| $1.82M | ﹤0.01% |
24,300
+8,200
| +51% | +$587K |
|
|
DCBO
4449
Docebo
DCBO
$585M
| $1.81M | ﹤0.01% |
+37,582
| New | +$1.68M |
|
|
RYZB
4450
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $1.81M | ﹤0.01% |
+29,186
| New | +$725K |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.